Genes & biomarkers

RET fusions and variants

RET · fusion / mutation · MEN2

Distinguish RET fusions in lung cancer from RET variants in medullary thyroid cancer.

Sources checked · Introductory guide

On this page

What does this result mean?

RET transmits cell signals. Certain germline RET variants cause hereditary conditions such as MEN2, but a tumor RET fusion should not automatically be interpreted as inherited.[1]

How does it connect to treatment?

Selpercatinib is used in selected RET fusion lung/thyroid cancers and RET-mutated medullary thyroid cancer. Criteria depend on the alteration type and cancer.[2]

What should I check in my report?

Check the fusion partner or exact variant. With medullary thyroid cancer or a suspected inherited finding, discuss germline testing and family counseling.

Questions for your care team

  • Is this a RET fusion or a RET variant needing genetic counseling?
  • Which treatments or trials fit my cancer type, stage and previous treatment?

Sources and scope

Source documents are in English.

Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.

  1. MedlinePlus Genetics · RET (opens in a new tab)
  2. NCI · selpercatinib (opens in a new tab)

General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.

Related entries

RET fusions and variants | Cancer Encyclopedia | My Chemo Diary